- HealthTech
- Tuesday, 09 Jun 2020
WuXi Biologics Signs Lease for a Clinical Manufacturing Facility in the United States
The new clinical manufacturing facility will install total 6000 L bioreactors, Process Development (PD), Quality Control (QC) labs, along with supporting functions. The 66,000-square-foot facility is expected to become operational in late 2020 and will bring in up to 100 jobs to the region.
This news follows WuXi Biologics' recent purchase of land to build a new 107,000-square-foot clinical and commercial manufacturing facility in Worcester, Massachusetts, and the lease of a 33,000-square-foot site to establish a process development lab in King of Prussia, Pennsylvania.
"We are excited to announce our third site in the United States and proud to become a member of the New Jersey community. Cranbury is a growing hub for the biotech and biopharma industries, and we look forward to working with and serving our partners in the area to benefit patients worldwide," said Dr. Chris Chen, CEO of WuXi Biologics.
Related Industry Updates
Europe RTLS for Healthcare Market Ready to Thrive during 2020-2027 with top Key Companies and Regional analysis I Centrak, IMPINJ
Jan 20, 2021
Global Patient Registry Software Market 2020 Introduction, Definition, Demand, Opportunities, Future Plans and Industry Scope by 2027| Medstreaming, Open Text Corporation, Evado Clinical, LUMEDX, CEDARON
Apr 19, 2021
NoSoapCompany: Smart Hand Sanitation Units in Public Spaces to Prevent New Corona Outbreak
Jun 22, 2020
Europe Surgical Suture Market Demand, Insights and Forecast up to 2027
Aug 11, 2020
Ambulatory EHR Market: Trends, Growth, Analysis, Opportunities ,Top Companies, And Overview 2027
Dec 23, 2020
North America Dental Surgery Instruments Market is Rising during 2020-2027 with Top Key Players Like 3M, Danaher, Hu-Friedy Mfg
Apr 22, 2021
Medically Prescribed Apps Market is Flourishing Worldwide with Top Vendors Y Media Labs, OpenXcell, ArcTouch, Contus, Intellectsoft US, SAVVY APPS, LLC
Mar 11, 2021
Follow us on
